Correction to: Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study (Advances in Therapy, (2019), 36, 4, (923-949), 10.1007/s12325-019-0895-1)

Ichiro Nakamura; Hiroshi Maegawa; Kazuyuki Tobe; Satoshi Uno

doi:10.1007/s12325-021-01813-8

Correction to: Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study (Advances in Therapy, (2019), 36, 4, (923-949), 10.1007/s12325-019-0895-1)

Ichiro Nakamura^*, Hiroshi Maegawa, Kazuyuki Tobe, Satoshi Uno

^*この論文の責任著者

内科学（第一）講座

研究成果: ジャーナルへの寄稿 › コメント/討論

抄録

In the original article, the Table 6 was published with some errors. The correct Table 6 is below. (Table presented.).

本文言語	英語
ページ（範囲）	4599-4601
ページ数	3
ジャーナル	Advances in Therapy
巻	38
号	8
DOI	https://doi.org/10.1007/s12325-021-01813-8
出版ステータス	出版済み - 2021/08

ASJC Scopus 主題領域

薬理学（医学）

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1007/s12325-021-01813-8

フィンガープリント

「Correction to: Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study (Advances in Therapy, (2019), 36, 4, (923-949), 10.1007/s12325-019-0895-1)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Nakamura, I., Maegawa, H., Tobe, K., & Uno, S. (2021). Correction to: Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study (Advances in Therapy, (2019), 36, 4, (923-949), 10.1007/s12325-019-0895-1). Advances in Therapy, 38(8), 4599-4601. https://doi.org/10.1007/s12325-021-01813-8

Nakamura, Ichiro ; Maegawa, Hiroshi ; Tobe, Kazuyuki その他. / Correction to : Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study (Advances in Therapy, (2019), 36, 4, (923-949), 10.1007/s12325-019-0895-1). In: Advances in Therapy. 2021 ; Vol. 38, No. 8. pp. 4599-4601.

@article{5e4dbceea598410e9535ab9bb2e49f2d,

title = "Correction to: Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study (Advances in Therapy, (2019), 36, 4, (923-949), 10.1007/s12325-019-0895-1)",

abstract = "In the original article, the Table 6 was published with some errors. The correct Table 6 is below. (Table presented.).",

author = "Ichiro Nakamura and Hiroshi Maegawa and Kazuyuki Tobe and Satoshi Uno",

note = "Publisher Copyright: {\textcopyright} Springer Healthcare Ltd., part of Springer Nature 2021",

year = "2021",

month = aug,

doi = "10.1007/s12325-021-01813-8",

language = "英語",

volume = "38",

pages = "4599--4601",

journal = "Advances in Therapy",

issn = "0741-238X",

publisher = "Adis",

number = "8",

}

Nakamura, I, Maegawa, H, Tobe, K & Uno, S 2021, 'Correction to: Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study (Advances in Therapy, (2019), 36, 4, (923-949), 10.1007/s12325-019-0895-1)', Advances in Therapy, vol. 38, no. 8, pp. 4599-4601. https://doi.org/10.1007/s12325-021-01813-8

Correction to: Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study (Advances in Therapy, (2019), 36, 4, (923-949), 10.1007/s12325-019-0895-1). / Nakamura, Ichiro; Maegawa, Hiroshi; Tobe, Kazuyuki その他.
In: Advances in Therapy, Vol. 38, No. 8, 08.2021, p. 4599-4601.

研究成果: ジャーナルへの寄稿 › コメント/討論

TY - JOUR

T1 - Correction to

T2 - Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study (Advances in Therapy, (2019), 36, 4, (923-949), 10.1007/s12325-019-0895-1)

AU - Nakamura, Ichiro

AU - Maegawa, Hiroshi

AU - Tobe, Kazuyuki

AU - Uno, Satoshi

PY - 2021/8

Y1 - 2021/8

N2 - In the original article, the Table 6 was published with some errors. The correct Table 6 is below. (Table presented.).

AB - In the original article, the Table 6 was published with some errors. The correct Table 6 is below. (Table presented.).

UR - http://www.scopus.com/inward/record.url?scp=85110803486&partnerID=8YFLogxK

U2 - 10.1007/s12325-021-01813-8

DO - 10.1007/s12325-021-01813-8

M3 - コメント/討論

C2 - 34279807

AN - SCOPUS:85110803486

SN - 0741-238X

VL - 38

SP - 4599

EP - 4601

JO - Advances in Therapy

JF - Advances in Therapy

IS - 8

ER -